Literature DB >> 16436739

A porphyrin increases survival time of mice after intracerebral prion infection.

David A Kocisko1, Winslow S Caughey, Richard E Race, Grant Roper, Byron Caughey, John D Morrey.   

Abstract

Prion diseases, including scrapie, are incurable neurodegenerative disorders. Some compounds can delay disease after a peripheral scrapie inoculation, but few are effective against advanced disease. Here, we tested multiple related porphyrins, but only Fe(III)meso-tetra(4-sulfonatophenyl)porphine injected into mouse brains after intracerebral scrapie inoculation substantially increased survival times.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436739      PMCID: PMC1366918          DOI: 10.1128/AAC.50.2.759-761.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Porphyrin and phthalocyanine antiscrapie compounds.

Authors:  S A Priola; A Raines; W S Caughey
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

2.  Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen.

Authors:  R Race; M Oldstone; B Chesebro
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Congo red prolongs the incubation period in scrapie-infected hamsters.

Authors:  L Ingrosso; A Ladogana; M Pocchiari
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

4.  Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease.

Authors:  N V Todd; J Morrow; K Doh-ura; S Dealler; S O'Hare; P Farling; M Duddy; N G Rainov
Journal:  J Infect       Date:  2005-06       Impact factor: 6.072

5.  Tetracyclines affect prion infectivity.

Authors:  Gianluigi Forloni; Selina Iussich; Tazeen Awan; Laura Colombo; Nadia Angeretti; Laura Girola; Ilaria Bertani; Giorgio Poli; Maria Caramelli; Maria Grazia Bruzzone; Laura Farina; Lucia Limido; Giacomina Rossi; Giorgio Giaccone; James W Ironside; Orso Bugiani; Mario Salmona; Fabrizio Tagliavini
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

6.  Prophylactic and therapeutic effects of phthalocyanine tetrasulfonate in scrapie-infected mice.

Authors:  Suzette A Priola; Anne Raines; Winslow Caughey
Journal:  J Infect Dis       Date:  2003-08-14       Impact factor: 5.226

Review 7.  Prion diseases--close to effective therapy?

Authors:  Neil R Cashman; Byron Caughey
Journal:  Nat Rev Drug Discov       Date:  2004-10       Impact factor: 84.694

8.  Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines.

Authors:  W S Caughey; L D Raymond; M Horiuchi; B Caughey
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

9.  Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters.

Authors:  M Pocchiari; S Schmittinger; C Masullo
Journal:  J Gen Virol       Date:  1987-01       Impact factor: 3.891

Review 10.  Approaches to prophylaxis and therapy.

Authors:  Dominique Dormont
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

View more
  16 in total

1.  Enhanced antiscrapie effect using combination drug treatment.

Authors:  David A Kocisko; Byron Caughey; John D Morrey; Richard E Race
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

2.  Identification of chemoattractive factors involved in the migration of bone marrow-derived mesenchymal stem cells to brain lesions caused by prions.

Authors:  Chang-Hyun Song; Osamu Honmou; Hidefumi Furuoka; Motohiro Horiuchi
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

3.  Diphenylpyrazole-derived compounds increase survival time of mice after prion infection.

Authors:  Fabienne Leidel; Martin Eiden; Markus Geissen; Hans A Kretzschmar; Armin Giese; Thomas Hirschberger; Paul Tavan; Hermann M Schätzl; Martin H Groschup
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

4.  Multimodal small-molecule screening for human prion protein binders.

Authors:  Andrew G Reidenbach; Michael F Mesleh; Dominick Casalena; Sonia M Vallabh; Jayme L Dahlin; Alison J Leed; Alix I Chan; Dmitry L Usanov; Jenna B Yehl; Christopher T Lemke; Arthur J Campbell; Rishi N Shah; Om K Shrestha; Joshua R Sacher; Victor L Rangel; Jamie A Moroco; Murugappan Sathappa; Maria Cristina Nonato; Kong T Nguyen; S Kirk Wright; David R Liu; Florence F Wagner; Virendar K Kaushik; Douglas S Auld; Stuart L Schreiber; Eric Vallabh Minikel
Journal:  J Biol Chem       Date:  2020-07-28       Impact factor: 5.157

5.  Prophylactic effect of dietary seaweed Fucoidan against enteral prion infection.

Authors:  Katsumi Doh-Ura; Tomoko Kuge; Miyuki Uomoto; Keiko Nishizawa; Yuri Kawasaki; Masahiko Iha
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

6.  meso-Tetra(pentafluorophenyl)porphyrin as an efficient platform for combinatorial synthesis and the selection of new photodynamic therapeutics using a cancer cell line.

Authors:  Diana Samaroo; Mikki Vinodu; Xin Chen; Charles Michael Drain
Journal:  J Comb Chem       Date:  2007-09-15

7.  Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions.

Authors:  Chang-Hyun Song; Osamu Honmou; Natsuo Ohsawa; Kiminori Nakamura; Hirofumi Hamada; Hidefumi Furuoka; Rie Hasebe; Motohiro Horiuchi
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

Review 8.  Recent advances in prion chemotherapeutics.

Authors:  Valerie L Sim; Byron Caughey
Journal:  Infect Disord Drug Targets       Date:  2009-02

9.  Cyclic tetrapyrrole sulfonation, metals, and oligomerization in antiprion activity.

Authors:  Winslow S Caughey; Suzette A Priola; David A Kocisko; Lynne D Raymond; Anne Ward; Byron Caughey
Journal:  Antimicrob Agents Chemother       Date:  2007-08-20       Impact factor: 5.191

10.  Prion Protein-Hemin Interaction Upregulates Hemoglobin Synthesis: Implications for Cerebral Hemorrhage and Sporadic Creutzfeldt-Jakob Disease.

Authors:  Ajai K Tripathi; Neena Singh
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.